Navigation Links
WeissComm Launches Invigorate Communications to Help Companies Build Successful Health-Based Brands
Date:10/14/2008

Tali Kaplan Joins as Associate Director

SAN FRANCISCO, and SUMMIT, N.J., Oct. 14 /PRNewswire-FirstCall/ -- WeissComm Group today announced that it has launched Invigorate Communications, a full-service public relations agency focused on serving the diverse communications needs of leading biopharmaceutical, device, healthcare service and consumer companies, particularly those interested in building health-based brands. Invigorate currently provides corporate, product, investor and advocacy communications support to several biopharmaceutical companies.

Invigorate leverages the success of WeissComm Partners, the largest, independent public relations firm focused exclusively on healthcare, which recently was named "Healthcare Agency of Year" by the Holmes Report.

"Clients have always come to WeissComm for senior level counselors who understand their business better than anyone," said Jim Weiss, CEO and chairman of WeissComm Group. "Now Invigorate also provides a team of professionals who are highly knowledgeable and passionate about healthcare and offer a unique combination of intelligence, strategy and hands-on service to support our clients' core business goals."

Led by Managing Director Tom Jones, Invigorate Communications is headquartered in Summit, N.J. with offices in San Francisco and Los Angeles. Jones was formerly an executive director of communications at Novartis Pharmaceuticals Corporation and an integral leader of Ketchum Public Relations' healthcare practice. He has a successful track record of developing and executing award-winning public relations and corporate communications initiatives focused on reaching consumers and encouraging interactive and productive dialogue between patients, caregivers and physicians.

WeissComm also announced that Tali Kaplan, a 20-year veteran of the healthcare industry, has been named associate director of Invigorate. She joins from CarryOn Communications, where she was
'/>"/>

SOURCE Invigorate Communications
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications
2. MRI Expands Energy Role: Launches Center for Integrated Algal Research and Creates Director of Energy Programs Position
3. Finesse Solutions Launches TruBio 3.4 Bioreactor Control Software
4. Finesse Solutions Launches Improved E-Store for Sensors and Transmitters
5. Allied Healthcare Launches First of Line of Ventilators Designed to Meet Demands of Mass Casualty Incidents
6. GenVault Corporation Launches GenTegra(TM) DNA
7. Complete Genomics Launches, Becomes Worlds First Large-Scale Human Genome Sequencing Company
8. Simbionix Launches Innovative Patient-Specific Simulation
9. CISBIO Bioassays Launches Chromoa(TM) Chromogranin A ELISA Kit
10. Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development
11. Histogen Launches BioNuesis, the Only All-Human Stem Cell Culturing Kit

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...N, Nov. 24 IES (Nasdaq: ... and communications systems and services for the c...ounced today that its commercial business group ha... to install the electrical systems for the Level 4...e U.S. Army Medical Research Institute of Infectio...
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswire... ) today announced that it has received notice fro...any,s common stock will be,suspended as of Novembe...e,Securities and Exchange Commission, which will r..., unless the company files an appeal to the Nasdaq...
(Date:11/24/2009)...TEO, Calif., Nov. 24 Neu... company focused on developing and commercializing...that Anthony DiTonno, President and Chief Executiv...ual Piper Jaffray Health Care Conference, to be he... in New York, New York. ,, Mr. DiTonno and Ste...
(Date:11/24/2009)...RE: HTL , TORONTO, Nov. 24 /PRNewswire-FirstC... Calotto Capital Inc., a leading provider of advan...l research and fertility clinic markets, today rep...ird quarter ended September 30, 2009. , , Q3 2...compared with $1.43 million in Q3 2008, - Gro...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10
...a-PRNewswire/ -- WuXi PharmaTech (NYSE:,WX), a lea...ice research,and development outsourcing company w...ay announced that it has promoted Dr. Rujian Ma to...http://www.newscom.com/cgi-bin/prnh/20040705/CNM00...ui Chen, Chief Scientific,Officer of WuXi PharmaTe...
...heid (Nasdaq:,CPHD) today announced that its execu...onferences, and invited investors to participate v...care Conference, Boston, MA Wednesday, Sept...W. Baird Small Cap Healthcare Conference, New York...a.m. Eastern Time, UBS Global Life Sciences...
...rapeutic Cellular Platform Utilizing Cord, Blood a...tion of Emergent Vascular...ternational, Inc. and EndGenitor Technologies, Inc...tion to co-develop a combined cellular,platform th...ed tissues.,Currently, intense research into the m...
Other Biology Technology:WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry 2Cepheid to Webcast Upcoming Financial Presentations 2Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration 2Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration 3Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration 4
(Date:11/23/2009)...-- More than 160 participants gathered this week f...RES INITIATIVE conference. This year,s topic, "Syn...neers, and medical researchers to explore the engi... the emerging field of synthetic biology. , Bonn...rinceton University and this year,s conference cha...
(Date:11/23/2009)...l. A new study provides "incontrovertible evidenc... island of Sumatra about 73,000 years ago deforest...e epicenter, researchers report. , The volcano e...to the atmosphere, leaving a crater (now the world...ong and 35 kilometers wide. Ash from the event has...
(Date:11/23/2009)...f. - By producing some of the highest resolution i...cientists have a deeper understanding how biomolec... may lead to a new treatment for kidney stones usi...n the Nov. 23 online edition of the journal Proce...res how peptides interact with mineral surfaces by...
Breaking Biology News(10 mins):Synthetic biology offers new opportunities for interdisciplinary collaboration 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3ForteBio Launches Dip and Read 28TM 29 Immunogenicity Assay Kit for Rapid Detection of Anti Drug Antibodies 57340 1ForteBio Launches Dip and Read 28TM 29 Immunogenicity Assay Kit for Rapid Detection of Anti Drug Antibodies 57340 2Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 1Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 2Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 3Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 4Pesticides Linked to Parkinsons 57331 1Pesticides Linked to Parkinsons 57331 2
...joined the ranks of investigators for the prestigi... 14 current HHMI investigators at Stanford, 11 of ... HHMI investigators nationwide. , Stanford,s reci...or of biology and of applied physics. His research...nd disease processes at the level of neural circui...
...sorder previously linked to lung disease may have ... cancer, according to a report in the May 26 issue.../Archives journals. , The disorder, alpha1-antitr... genetic conditions affecting the U.S. population ...g to background information in the article. Indivi...
...laureates, including Al Gore and Sir Tom Stoppard,...a ceremony held May 19 at Tel Aviv University. Isr...ss. , Laureates were selected based on their acti...nt and future. , Al Gore: Our Present Responsibi...illion prize for his present work in Social Respon...
Other Biology News:4 Stanford faculty named Howard Hughes Medical Institute Investigators 2Genetic mutation associated with increased risk of lung cancer 2Al Gore and Tom Stoppard among 2008 Dan David Prize Winners at TAU 2
Mouse Anti-Human PPP2R2C Monoclonal Antibody, Unconjugated, Clone 6D1 from Novus Biologicals
Mouse Anti-Human BTG2 Polyclonal Antibody, Unconjugated from Novus Biologicals
Attofluor cell chamber from Molecular Probes (Invitrogen)
...A quantitation kit is used to quantitate double-st...ce of RNA or protein. With this kit, DNA is staine...th a VersaFluor or other fluorometer. The kit quan...crograms per ml and contains Hoechst 33258, calf t...
Biology Products: